Vaxine Shigella Vaccine
Shigellosis
PreclinicalActive
Key Facts
About Vaxine
AI‑enhanced vaccine developer using the Advax™ adjuvant platform for infectious disease and immunotherapy.
View full company profileTherapeutic Areas
Other Shigellosis Drugs
| Drug | Company | Phase |
|---|---|---|
| Shigella Vaccine Candidate | Valneva | Phase 2 |
| Shigella Vaccine | Inventprise | Not Disclosed |